Humana Inc. (NYSE:HUM) Given Consensus Rating of “Hold” by Brokerages

Shares of Humana Inc. (NYSE:HUM) have been given an average rating of “Hold” by the twenty-five research firms that are currently covering the company, MarketBeat reports. Nineteen analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. The average 1-year price objective among analysts that have updated their coverage on the stock in the last year is $315.86.

HUM has been the topic of several research analyst reports. Bank of America raised Humana from an “underperform” rating to a “neutral” rating and boosted their price target for the stock from $247.00 to $308.00 in a research note on Wednesday, November 6th. TD Cowen boosted their price target on Humana from $261.00 to $268.00 and gave the stock a “hold” rating in a research note on Monday, November 4th. Truist Financial decreased their price target on Humana from $400.00 to $260.00 and set a “hold” rating on the stock in a research note on Friday, October 11th. JPMorgan Chase & Co. boosted their price target on Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on Humana from $349.00 to $250.00 and set a “hold” rating for the company in a research report on Thursday, October 3rd.

Humana Price Performance

Shares of HUM opened at $285.82 on Wednesday. Humana has a twelve month low of $213.31 and a twelve month high of $488.89. The stock’s 50 day moving average is $272.07 and its two-hundred day moving average is $326.37. The firm has a market capitalization of $34.42 billion, a PE ratio of 25.32, a P/E/G ratio of 2.18 and a beta of 0.53. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 earnings per share for the quarter, beating analysts’ consensus estimates of $3.48 by $0.68. The company had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Research analysts anticipate that Humana will post 16.14 earnings per share for the current year.

Humana Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.24%. Humana’s payout ratio is 31.36%.

Institutional Trading of Humana

Institutional investors and hedge funds have recently made changes to their positions in the company. PDT Partners LLC increased its holdings in shares of Humana by 190.0% during the 3rd quarter. PDT Partners LLC now owns 4,060 shares of the insurance provider’s stock worth $1,286,000 after buying an additional 2,660 shares during the last quarter. Ontario Teachers Pension Plan Board increased its holdings in shares of Humana by 6.5% during the 3rd quarter. Ontario Teachers Pension Plan Board now owns 1,173,535 shares of the insurance provider’s stock worth $371,705,000 after buying an additional 71,910 shares during the last quarter. Swedbank AB increased its holdings in shares of Humana by 3.0% during the 3rd quarter. Swedbank AB now owns 105,976 shares of the insurance provider’s stock worth $33,567,000 after buying an additional 3,085 shares during the last quarter. Heritage Oak Wealth Advisors LLC acquired a new stake in shares of Humana during the 2nd quarter worth $3,456,000. Finally, Charles Schwab Investment Management Inc. increased its holdings in shares of Humana by 3.0% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 899,191 shares of the insurance provider’s stock worth $284,810,000 after buying an additional 26,056 shares during the last quarter. 92.38% of the stock is currently owned by institutional investors and hedge funds.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.